vTv Therapeutics annual free cash flow
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
vTv Therapeutics Free Cash Flow (FCF) History (VTVT)
vTv Therapeutics reported −$25.3M in free cash flow for fiscal 2024, a decrease of $6.2M from the previous fiscal year, with a free cash flow margin of −2488.40%.
View full vTv Therapeutics company overviewvTv Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$25.3M | −$6.2M | — | −2488.40% |
| 2023 | 2023-12-31 | −$19.1M | −$3.0M | — | — |
| 2022 | 2022-12-31 | −$16.0M | $3.3M | — | −795.00% |
| 2021 | 2021-12-31 | −$19.3M | −$1.3M | — | −482.10% |
| 2020 | 2020-12-31 | −$18.0M | $5.1M | — | −280.64% |
| 2019 | 2019-12-31 | −$23.1M | $3.8M | — | −835.31% |
| 2018 | 2018-12-31 | −$26.9M | $17.8M | — | −216.03% |
| 2017 | 2017-12-31 | −$44.6M | $3.7M | — | −15332.30% |
| 2016 | 2016-12-31 | −$48.3M | −$11.2M | — | −7617.67% |
| 2015 | 2015-12-31 | −$37.0M | −$6.2M | — | −7138.73% |
| 2014 | 2014-12-31 | −$30.8M | $11.1M | — | −1989.15% |
| 2013 | 2013-12-31 | −$41.9M | — | — | −4289.45% |
vTv Therapeutics quarterly free cash flow
Q1.15
Q2.15
Q3.15
Q4.15
Q3.16
Q1.17
Q2.17
Q3.17
Q4.17
Q3.21
Q3.22
Q3.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2023 | 2023-09-30 | −$4.8M | $6.9M | — | — |
| Q3 2022 | 2022-09-30 | −$8.8M | $3.8M | — | — |
| Q3 2021 | 2021-09-30 | −$3.6M | $10.3M | — | −119.80% |
| Q4 2017 | 2017-12-31 | −$6.3M | $6.4M | — | −2724.89% |
| Q3 2017 | 2017-09-30 | −$11.8M | −$2.7M | — | −78506.67% |
| Q2 2017 | 2017-06-30 | −$12.6M | −$2.8M | — | −97207.69% |
| Q1 2017 | 2017-03-31 | −$13.9M | −$5.0M | — | −46183.33% |
| Q3 2016 | 2016-09-30 | −$12.7M | −$3.4M | — | −33494.74% |
| Q4 2015 | 2015-12-31 | −$9.0M | — | — | −3996.46% |
| Q3 2015 | 2015-09-30 | −$9.8M | — | — | −7391.73% |
| Q2 2015 | 2015-06-30 | −$8.8M | — | — | −8015.45% |
| Q1 2015 | 2015-03-31 | −$9.4M | — | — | −18740.00% |
vTv Therapeutics free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$23.1M to −$25.3M, a net decrease of $2.2M. vTv Therapeutics's latest reported quarter, Q3 2023, generated −$4.8M in free cash flow, an increase of $6.9M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review vTv Therapeutics filings at SEC.gov ↗